| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |